维普期刊资源整合服务平台（V6.5）

227篇 您的检索式：作者名="Symmans"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	Mammotome core biosy for mammary microcalcification: analysis of 160 biopsies from 142 women with surgical and radiologic follow up显示文摘	Cangiarella J Waisman J Symmans WF	2001	Cancer2001，91，1：	1
2	The HER-2receptor and breast cancer:ten years of targeted anti HER-2therapy andpersonalized medicine显示文摘	Ross JS Slodkowska EA Symmans WF	2009	Oncologist2009，14，：	1
3	Phase Ⅰ/Ⅱ study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer 显示文摘	Moulder SL Symmans WF Booser DJ	2008	Clin Cancer Res2008，14，23：	1
4	Breast cancer molecular subtypes respond differently to preoperative chemotherapy 显示文摘	Rouzier R Perou CM Symmans WF	2005	Clin Cancer Res2005，11，16：	1
5	Aggressive angiomyxoma of the female genital tract and pelvis - clinicopathologic features with immunohistochemical analysis 显示文摘	Bigby SM Symmans PJ Miller MV	2011	Int J Gynecol Pathol2011，30，5：	1
6	Breast cancer molecular subtypes respond differently to preoperative chemotherapy显示文摘	Rouzier R Perou CM Symmans WF		0，，16：	1
7	Breast cancer mo- lecular subtypes respond differently to preoperative chemo- therapy显示文摘	Rouzier R Perou CM Symmans WF	2005	Clin Cancer Res2005，11，16：	1
8	The HER-2 receptor and breast cancer:ten years of targeted anti-her-2 therapy and personalized medicine显示文摘	Ross JS Slodkowska EA Symmans WF	2009	The Oncologist2009，14，4：	1
9	Triple negative breast carci- noma and the basal phenotype: from expression profiling to clinical practice 显示文摘	Diaz LK Cryns VL Symmans WF	2007	Adv Anat Patho12007，14，6：	1
10	The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine 显示文摘	Ross JS Slodkowska EA Symmans WF	2009	Oncologist2009，14，4：	1
11	Measurement of Re- sidual Breast Cancer Burden to Predict Survival After Neoadju- vant Chemotherapy显示文摘	Symmans WF Peintinger F Hatzis C	2007	J Clin Oncol2007，25，28：	1
12	Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer 显示文摘	Hess RK Anderson K Symmans WF	2006	J Gin Oncol2006，24，26：	1
13	Immunohistochemistry and proliferative activity in Lhermitte-Duclos disease 显示文摘	Hair LS Symmans F Powers JM	1992	Acta Neuropathol (Berl)1992，84，：	1
14	Paelitaxel-Induced Apoptosis and Mitotic Arrest Assessed by Serial Fine-Needle Aspiration : Implications for Early Prediction of Breast Cancer Response to Neoadjuvant Treatment 显示文摘	SYMMANS W F VOLM M D SHAPIRO R L PERKINS A B KIM A Y DEMARIA S YEE H T MCMULLEN H ORATZ R KLEIN P FORMENTI S C MUGGIA F	2000	Clin Cancer Res2000，6，12：	1
15	Breast cancer molecular subtypes respond differently to preoperative chemotherapy显示文摘	Rouzier R Perou CM Symmans WF	2005	Clin Cancer Res2005，11，16：	1
16	Breast cancer molecular subtypes respond differently to preoperative chemot herapy 显示文摘	Rouzier R Perou CM Symmans WF	2005	Clin Cancer Res2005，11，16：	1
17	Breast cancer molecular subtypes respond differently to preoperative chemotherapy显示文摘	Rouzier R Perou CM Symmans WF	2005	Clin Cancer Res2005，11，16：	1
18	Development of pharmacogenomic markers to select preoperative chemotherapy for breast cancer 显示文摘	Pusztai L Symmans FW Hortobagyi GN	2005	Breast Cancer2005，12，2：	1
19	Commercialized multigene predictors of clinical outcome for breast cancer显示文摘	Ross JS Hatzis C Symmans WF	2008	Oncologist2008，13，5：	1
20	Pathologic changes in breast cancer following neoadjuvant chemotherapy: implications for the assessment of response 显示文摘	Rajah R Esteva FJ Symmans WF	2004	Clin Breast Cancer2004，5，3：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示